2019

12/06/2019 Guerbet strengthens its commitment to Women’s Health

• The company will attend the 2019 RCOG World Conference in London & ESHRE Annual Meeting in Vienna • Guerbet also highlights the value of Hysterosalpingography (HSG) in Infertility Management Villepinte (France), June 12, 2019 - Guerbet (FR0000032526 GBT), a global specialist...

[more]


05/06/2019 New indication approved for Guerbet’s Lipiodol® Ultra Fluid

Lipiodol® Ultra Fluid now approved for conventional trans-arterial chemoembolization of intermediate-stage hepatocellular carcinoma in Switzerland and in India

[more]


06/05/2019 Guerbet shows its commitment to supporting professionals in the field of interventional imaging with its launch of a specialized website

Villepinte (France), May 6, 2019 – Guerbet, a global specialist in contrast agents and solutions for medical imaging, has announced the launch of its website for interventional radiologists, specializing particularly in the fields of oncology and vascular embolization:...

[more]


06/05/2019 Guerbet commits to supporting women’s health with its launch of a specialized website

Villepinte (France), May 6, 2019 – Guerbet, a global specialist in contrast agents and solutions for medical imaging, has announced the creation of a specialized website for healthcare professionals dedicated to women’s health and in particular to issues relating to the diagnosis and treatment of...

[more]


30/04/2019 ASPIRE 2019, Guerbet involved in Women’s Healthcare!

A major event, the ASPIRE congress brings together international health professionals with interest in reproductive medicine and fertilityOrganization of a symposium “Current & Future Trends of Hysterosalpingography (HSG) in Clinical Practice” on May 4 from 15:00 to 16:30 The 9th Congress of...

[more]


24/04/2019 Guerbet receives CE mark approval for SeQure® and DraKon™ microcatheters for interventional imaging

Villepinte, France, April 24th, 2019 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces the upcoming European launch of SeQure® and DraKon™, two novel microcatheters for peripheral embolization procedures. SeQure® and DraKon™...

[more]


18/04/2019 1st quarter 2019 revenue

1st quarter 2019 revenue Year off to a good start: • €197.3 million; +7.7% at current exchange rates• €195.4 million; +6.7% at constant exchange rates Villepinte, 18 April 2019 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is...

[more]


Displaying results 8 to 14 out of 18